Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells

Carmelo Carlo-Stella, Ester Regazzi, Daniela Garau, Lina Mangoni, Maria Teresa Rizzo, Antonio Bonati, Gianpietro Dotti, Camillo Almici, Vittorio Rizzoli

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Receptor and nonreceptor protein tyrosine kinases (PTKs) play a key role in the control of normal and neoplastic cell growth. The availability of PTK inhibitors prompted us to evaluate the effects of genistein, a natural inhibitor of PTKs, on in vitro colony formation by normal multilineage colony-forming units (CFU-Mix), erythroid bursts (BFU-E), granulocyte-macrophage colony-forming units (CFU-GM), long-term culture-initiating cells (LTC-IC) and acute myelogenous leukaemia colony-forming units (CFU-AML). Continuous exposure of normal marrow and blood mononuclear non-adherent cells, blood CD34+CD45RA- cells, and leukaemic blasts to increasing doses of genistein (1-100μM) resulted in a statistically significant (P <0.05) dose-dependent suppression of CFU-Mix, BFU-E, CFU-GM and CFU-AML growth. Regression analysis showed that growth inhibition was linearly related to genistein concentration, Genistein dose causing 50% inhibition (ID50) of CFU-AML was significantly lower compared to CFU-GM ID50 for marrow (19 v 32μM, P ≤0.017), unseparated blood (19 v 44μM, P ≤ 0.028) or CD344+CD45RA- blood (19 v 36, P≤0.04). Preincubation of leukaemic blasts with genistein (200μM) for 1-2 h confirmed that CFU-AML were significantly more sensitive than normal marrow and blood CFU-GM to genistein. Preincubation conditions which maximally suppressed leukaemic and normal colony growth spared a substantial percentage of marrow (29±4%) and blood (40±3%) LTC-IC. In conclusion, our data demonstrate that: (a) genistein strongly inhibits the growth of normal and leukaemic haemopoietic progenitors; (b) growth inhibition is dose- and time-dependent; (c) leukaemic progenitors are more sensitive than normal progenitors to genistein-induced growth inhibition; (d) genistein exerts a direct toxic effect on haemopoietic cells while sparing a substantial proportion of LTC-IC. The potent CFU-AML growth inhibition associated with the relative resistance of normal LTC-IC strongly supports the use of genistein for marrow purging.

Original languageEnglish
Pages (from-to)551-557
Number of pages7
JournalBritish Journal of Haematology
Volume93
Issue number3
Publication statusPublished - 1996

Fingerprint

Genistein
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Stem Cells
Granulocyte-Macrophage Progenitor Cells
Growth
Bone Marrow
Cell Culture Techniques
Erythroid Precursor Cells
Poisons
Receptor Protein-Tyrosine Kinases
Acute Myeloid Leukemia
Blood Cells
Regression Analysis

Keywords

  • Genistein
  • LTC-IC
  • Marrow purging
  • Progenitor cells
  • Protein-tyrosine kinases

ASJC Scopus subject areas

  • Hematology

Cite this

Carlo-Stella, C., Regazzi, E., Garau, D., Mangoni, L., Rizzo, M. T., Bonati, A., ... Rizzoli, V. (1996). Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells. British Journal of Haematology, 93(3), 551-557.

Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells. / Carlo-Stella, Carmelo; Regazzi, Ester; Garau, Daniela; Mangoni, Lina; Rizzo, Maria Teresa; Bonati, Antonio; Dotti, Gianpietro; Almici, Camillo; Rizzoli, Vittorio.

In: British Journal of Haematology, Vol. 93, No. 3, 1996, p. 551-557.

Research output: Contribution to journalArticle

Carlo-Stella, C, Regazzi, E, Garau, D, Mangoni, L, Rizzo, MT, Bonati, A, Dotti, G, Almici, C & Rizzoli, V 1996, 'Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells', British Journal of Haematology, vol. 93, no. 3, pp. 551-557.
Carlo-Stella, Carmelo ; Regazzi, Ester ; Garau, Daniela ; Mangoni, Lina ; Rizzo, Maria Teresa ; Bonati, Antonio ; Dotti, Gianpietro ; Almici, Camillo ; Rizzoli, Vittorio. / Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells. In: British Journal of Haematology. 1996 ; Vol. 93, No. 3. pp. 551-557.
@article{05e8fed974604779a35229f9dd8cd944,
title = "Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells",
abstract = "Receptor and nonreceptor protein tyrosine kinases (PTKs) play a key role in the control of normal and neoplastic cell growth. The availability of PTK inhibitors prompted us to evaluate the effects of genistein, a natural inhibitor of PTKs, on in vitro colony formation by normal multilineage colony-forming units (CFU-Mix), erythroid bursts (BFU-E), granulocyte-macrophage colony-forming units (CFU-GM), long-term culture-initiating cells (LTC-IC) and acute myelogenous leukaemia colony-forming units (CFU-AML). Continuous exposure of normal marrow and blood mononuclear non-adherent cells, blood CD34+CD45RA- cells, and leukaemic blasts to increasing doses of genistein (1-100μM) resulted in a statistically significant (P <0.05) dose-dependent suppression of CFU-Mix, BFU-E, CFU-GM and CFU-AML growth. Regression analysis showed that growth inhibition was linearly related to genistein concentration, Genistein dose causing 50{\%} inhibition (ID50) of CFU-AML was significantly lower compared to CFU-GM ID50 for marrow (19 v 32μM, P ≤0.017), unseparated blood (19 v 44μM, P ≤ 0.028) or CD344+CD45RA- blood (19 v 36, P≤0.04). Preincubation of leukaemic blasts with genistein (200μM) for 1-2 h confirmed that CFU-AML were significantly more sensitive than normal marrow and blood CFU-GM to genistein. Preincubation conditions which maximally suppressed leukaemic and normal colony growth spared a substantial percentage of marrow (29±4{\%}) and blood (40±3{\%}) LTC-IC. In conclusion, our data demonstrate that: (a) genistein strongly inhibits the growth of normal and leukaemic haemopoietic progenitors; (b) growth inhibition is dose- and time-dependent; (c) leukaemic progenitors are more sensitive than normal progenitors to genistein-induced growth inhibition; (d) genistein exerts a direct toxic effect on haemopoietic cells while sparing a substantial proportion of LTC-IC. The potent CFU-AML growth inhibition associated with the relative resistance of normal LTC-IC strongly supports the use of genistein for marrow purging.",
keywords = "Genistein, LTC-IC, Marrow purging, Progenitor cells, Protein-tyrosine kinases",
author = "Carmelo Carlo-Stella and Ester Regazzi and Daniela Garau and Lina Mangoni and Rizzo, {Maria Teresa} and Antonio Bonati and Gianpietro Dotti and Camillo Almici and Vittorio Rizzoli",
year = "1996",
language = "English",
volume = "93",
pages = "551--557",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "3",

}

TY - JOUR

T1 - Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells

AU - Carlo-Stella, Carmelo

AU - Regazzi, Ester

AU - Garau, Daniela

AU - Mangoni, Lina

AU - Rizzo, Maria Teresa

AU - Bonati, Antonio

AU - Dotti, Gianpietro

AU - Almici, Camillo

AU - Rizzoli, Vittorio

PY - 1996

Y1 - 1996

N2 - Receptor and nonreceptor protein tyrosine kinases (PTKs) play a key role in the control of normal and neoplastic cell growth. The availability of PTK inhibitors prompted us to evaluate the effects of genistein, a natural inhibitor of PTKs, on in vitro colony formation by normal multilineage colony-forming units (CFU-Mix), erythroid bursts (BFU-E), granulocyte-macrophage colony-forming units (CFU-GM), long-term culture-initiating cells (LTC-IC) and acute myelogenous leukaemia colony-forming units (CFU-AML). Continuous exposure of normal marrow and blood mononuclear non-adherent cells, blood CD34+CD45RA- cells, and leukaemic blasts to increasing doses of genistein (1-100μM) resulted in a statistically significant (P <0.05) dose-dependent suppression of CFU-Mix, BFU-E, CFU-GM and CFU-AML growth. Regression analysis showed that growth inhibition was linearly related to genistein concentration, Genistein dose causing 50% inhibition (ID50) of CFU-AML was significantly lower compared to CFU-GM ID50 for marrow (19 v 32μM, P ≤0.017), unseparated blood (19 v 44μM, P ≤ 0.028) or CD344+CD45RA- blood (19 v 36, P≤0.04). Preincubation of leukaemic blasts with genistein (200μM) for 1-2 h confirmed that CFU-AML were significantly more sensitive than normal marrow and blood CFU-GM to genistein. Preincubation conditions which maximally suppressed leukaemic and normal colony growth spared a substantial percentage of marrow (29±4%) and blood (40±3%) LTC-IC. In conclusion, our data demonstrate that: (a) genistein strongly inhibits the growth of normal and leukaemic haemopoietic progenitors; (b) growth inhibition is dose- and time-dependent; (c) leukaemic progenitors are more sensitive than normal progenitors to genistein-induced growth inhibition; (d) genistein exerts a direct toxic effect on haemopoietic cells while sparing a substantial proportion of LTC-IC. The potent CFU-AML growth inhibition associated with the relative resistance of normal LTC-IC strongly supports the use of genistein for marrow purging.

AB - Receptor and nonreceptor protein tyrosine kinases (PTKs) play a key role in the control of normal and neoplastic cell growth. The availability of PTK inhibitors prompted us to evaluate the effects of genistein, a natural inhibitor of PTKs, on in vitro colony formation by normal multilineage colony-forming units (CFU-Mix), erythroid bursts (BFU-E), granulocyte-macrophage colony-forming units (CFU-GM), long-term culture-initiating cells (LTC-IC) and acute myelogenous leukaemia colony-forming units (CFU-AML). Continuous exposure of normal marrow and blood mononuclear non-adherent cells, blood CD34+CD45RA- cells, and leukaemic blasts to increasing doses of genistein (1-100μM) resulted in a statistically significant (P <0.05) dose-dependent suppression of CFU-Mix, BFU-E, CFU-GM and CFU-AML growth. Regression analysis showed that growth inhibition was linearly related to genistein concentration, Genistein dose causing 50% inhibition (ID50) of CFU-AML was significantly lower compared to CFU-GM ID50 for marrow (19 v 32μM, P ≤0.017), unseparated blood (19 v 44μM, P ≤ 0.028) or CD344+CD45RA- blood (19 v 36, P≤0.04). Preincubation of leukaemic blasts with genistein (200μM) for 1-2 h confirmed that CFU-AML were significantly more sensitive than normal marrow and blood CFU-GM to genistein. Preincubation conditions which maximally suppressed leukaemic and normal colony growth spared a substantial percentage of marrow (29±4%) and blood (40±3%) LTC-IC. In conclusion, our data demonstrate that: (a) genistein strongly inhibits the growth of normal and leukaemic haemopoietic progenitors; (b) growth inhibition is dose- and time-dependent; (c) leukaemic progenitors are more sensitive than normal progenitors to genistein-induced growth inhibition; (d) genistein exerts a direct toxic effect on haemopoietic cells while sparing a substantial proportion of LTC-IC. The potent CFU-AML growth inhibition associated with the relative resistance of normal LTC-IC strongly supports the use of genistein for marrow purging.

KW - Genistein

KW - LTC-IC

KW - Marrow purging

KW - Progenitor cells

KW - Protein-tyrosine kinases

UR - http://www.scopus.com/inward/record.url?scp=0029949993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029949993&partnerID=8YFLogxK

M3 - Article

C2 - 8652372

AN - SCOPUS:0029949993

VL - 93

SP - 551

EP - 557

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -